aspirin has been researched along with 9,10-dimethyl-1,2-benzanthracene in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Shoyab, M | 1 |
Perkins, TM; Shklar, G | 1 |
Abbadessa, G; Carletti, M; Dacasto, M; Di Carlo, F; Gardini, G; Girolami, F; Nebbia, C; Piccione, F; Racca, S; Spaccamiglio, A | 1 |
de Lumen, BO; Hernández-Ledesma, B; Hsieh, CC | 1 |
Ho, CT; Huang, MT; Lin, CC; Liu, Y | 1 |
Li, Y; Liao, Q; Liu, Q; Lu, Z; Niu, Z; Wang, M; Yao, L; Zhao, Y; Zong, Y | 1 |
6 other study(ies) available for aspirin and 9,10-dimethyl-1,2-benzanthracene
Article | Year |
---|---|
Effects of prostaglandins and some anti-inflammatory drugs on the binding of 7,12-dimethylbenz[alpha]anthracene to the DNA of murine epidermal cells in culture.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anti-Inflammatory Agents; Aspirin; Benz(a)Anthracenes; Cells, Cultured; DNA; Flufenamic Acid; Fluocinolone Acetonide; Indomethacin; Mice; Prostaglandins E, Synthetic; Prostaglandins F, Synthetic; Skin | 1979 |
Delay in hamster buccal pouch carcinogenesis by aspirin and indomethacin.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Oral; Animals; Aspirin; Carcinoma, Squamous Cell; Cheek; Cricetinae; Female; Indomethacin; Male; Mesocricetus; Mouth Neoplasms; Neoplasms, Experimental; Time Factors | 1982 |
Time-dependent acetylsalicylic acid effects on liver CYP1A and antioxidant enzymes in a rat model of 7,12-dimethylbenzanthracene (DMBA)-induced mammary carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Antioxidants; Aspirin; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Cytochromes; Female; Glucuronosyltransferase; Glutathione; Glutathione Transferase; Liver; Mammary Neoplasms, Experimental; NAD(P)H Dehydrogenase (Quinone); Rats; Rats, Sprague-Dawley | 2008 |
Lunasin-aspirin combination against NIH/3T3 cells transformation induced by chemical carcinogens.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Anacardic Acids; Animals; Anticarcinogenic Agents; Antineoplastic Combined Chemotherapy Protocols; Aspirin; Carcinogens; Cell Line, Transformed; Cell Proliferation; Cell Transformation, Neoplastic; Methylcholanthrene; Mice; NIH 3T3 Cells; Soybean Proteins | 2011 |
Inhibitory effects of 1,3-bis-(2-substituted-phenyl)-propane-1,3-dione, β-diketone structural analogues of curcumin, on chemical-induced tumor promotion and inflammation in mouse skin.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anti-Inflammatory Agents; Arachidonic Acid; Aspirin; Carcinogens; Curcumin; Dermatitis; Ear, External; Edema; Female; Ketones; Mice; Mice, Inbred Strains; Platelet Aggregation Inhibitors; Skin Neoplasms; Tetradecanoylphorbol Acetate | 2011 |
Atorvastatin (Lipitor) attenuates the effects of aspirin on pancreatic cancerogenesis and the chemotherapeutic efficacy of gemcitabine on pancreatic cancer by promoting M2 polarized tumor associated macrophages.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antimetabolites, Antineoplastic; Aspirin; Atorvastatin; Cell Line; Cell Proliferation; Deoxycytidine; Drug Synergism; Gemcitabine; Gene Expression Regulation, Neoplastic; Macrophages; Male; Mice; Pancreatic Neoplasms; Xenograft Model Antitumor Assays | 2016 |